ProteinBase is an open data hub of validated proteins and design methods.

Adaptyv Biosystems: Innovating protein engineering with advanced technology.
Adaptyv Biosystems, founded with a mission to revolutionize protein engineering, leverages cutting-edge cell-free synthetic biology and nanofluidics. The company's core vision is to accelerate the development of novel proteins for various applications, including therapeutics, diagnostics, and industrial enzymes. Their innovative platform enables rapid and precise protein design, catering to the needs of biotechnology and pharmaceutical markets.
Notable figures associated with Adaptyv Biosystems include leading experts in synthetic biology and nanotechnology. The company has attracted significant investment from prominent venture capital firms, underscoring its potential impact. Key achievements include the successful development of their proprietary protein engineering platform, which has garnered attention for its efficiency and scalability. Adaptyv Biosystems is poised to make substantial contributions to the fields of medicine and biotechnology through its groundbreaking technology.

A-Alpha Bio
aalphabio.com

Profluent Bio
profluent.bio

AI Proteins
aiproteinstx.com

Evozyne
evozyne.com

Proteinea
proteinea.com

Synlife
synlifebio.com

BrickBio
brickbio.com

Twist Bioscience

Catena Biosciences

Think Bioscience

ActivSignal
activsignal.com

Protein Dynamic Solutions
pdsbio.com

Cellanome
cellanome.com

Tierra Biosciences

Liberation Labs
liberationlabs.com
Companies similar to Adaptyv Biosystems include A-Alpha Bio, Profluent Bio, AI Proteins and Evozyne.
Adaptyv Biosystems was founded in 2020.
Adaptyv Biosystems' headquarters is located in Lausanne, canton Vaud, CH.
Adaptyv Biosystems' most recent funding round was for CHF100k (CHF) in June 2023.
As of Jun 1, 2023, Adaptyv Biosystems has disclosed funding of $3.1M (USD). Undisclosed round amounts are excluded.
Adaptyv Biosystems has 7 employees as of Feb 24, 2024.